Seeing Is Believing
with an average price target of $44.12. This is a potential upside of $25.12 (132.21%) from yesterday's end of day stock price of $19.
Intercept Pharmaceuticals's activity chart (see below) currently has 451 price targets and 330 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.47% with an average time for these price targets to be met of 72.05 days.
Most recent stock forecast was given by NAVIN JACOB from UBS on 26-Sep-2023. First documented stock forecast 12-Aug-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$19
$12
2 years 13 days ago
(26-Sep-2023)
5/8 (62.5%)
$0.42 (2.26%)
137
Hold
$19
$13
2 years 13 days ago
(26-Sep-2023)
9/22 (40.91%)
$0.42 (2.26%)
25
Buy
$19
$18
2 years 14 days ago
(25-Sep-2023)
5/25 (20%)
$0.29 (1.55%)
72
Buy
$19
$12
2 years 3 months 11 days ago
(28-Jun-2023)
2/6 (33.33%)
$7.83 (70.10%)
74
Sell
$14
2 years 4 months 18 days ago
(21-May-2023)
7/10 (70%)
$-1.09 (-7.22%)
54
What is ICPT (Intercept Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ICPT (Intercept Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ICPT (Intercept Pharmaceuticals)?
Which analyst is the currently most bullish on ICPT (Intercept Pharmaceuticals)?
Which analyst is the currently most reserved on ICPT (Intercept Pharmaceuticals)?